Dr. Sanjay  Rajagopalan, MD

Dr. Sanjay Rajagopalan, MD

Case Western Reserve University

Chief Of Cardiovascular Medicine, University Hospitals, CAO/CSO Harrington Heart and Vascular Institute, Professor at CWRU School of Medicine

Expertise: Heart DiseaseVascularCardiovascular Healthcardiovascular imagingDiabetesHypertensionVascular MedicinePreventive Cardiologylipid managementComputed Tomography

Dr. Sanjay Rajagopalan is the Chief of Cardiovascular Medicine for University Hospitals Harrington Heart & Vascular Institute, the Herman K. Hellerstein, MD Professor of Cardiovascular Research, and Director of the Case Cardiovascular Research Institute at Case Western Reserve University School of Medicine in Cleveland, Ohio.

Dr. Rajagopalan completed internal medicine training, including serving as Chief Resident, at SUNY (Buffalo, New York), Clinical and Research Fellowships in Cardiovascular Medicine/Vascular Biology at the Emory University School of Medicine (Atlanta, Georgia) and Cardiovascular Magnetic Resonance Imaging training at Duke University Medical Center (Durham, North Carolina).

Dr. Rajagopalan is among an elite group of physician scientists whose work has helped transform global perceptions of the impact of the environment on cardiovascular health. He is passionate about technology innovation in cardiovascular medicine for the development of personalized approaches to heart disease prevention.

Dr. Rajagopalan is an elected member of the American Society of Clinical Investigation (ASCI), American Association of Physicians (AAP), Association of University Cardiologists (AUC) and the Association of Professors of Cardiology (APC).

No Research/Citations

CWRU and UH researchers secure $6.2 million from NIH to investigate using artificial intelligence to predict cardiovascular disease

Researchers from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence (AI) approaches.
24-Apr-2023 10:30:26 AM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video